Motus GI Holdings Inc MOTS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $0.03
- Day Range
- $0.03–0.04
- 52-Week Range
- $0.02–10.05
- Bid/Ask
- $0.03 / $0.04
- Market Cap
- $247,888.39
- Volume/Avg
- 15,925 / 77,554
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.08
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Motus GI Holdings Inc is a medical technology company dedicated to improving endoscopy outcomes, lowering costs, and enhancing patient experiences. The company has developed the Pure-Vu System, a medical device that has been cleared by the U.S. Food and Drug Administration (the FDA) to help facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal (GI) endoscopy procedures. The Pure-Vu System is also CE marked in the European Economic Area (EEA) for use in colonoscopy.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 15
- Website
- https://www.motusgi.com
Valuation
|
Metric
|
MOTS
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.06 |
Price/Sales | 0.08 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
MOTS
|
|---|---|
Quick Ratio | 1.52 |
Current Ratio | 1.74 |
Interest Coverage | −14.24 |
Quick Ratio
MOTS
Profitability
|
Metric
|
MOTS
|
|---|---|
Return on Assets (Normalized) | −103.39% |
Return on Equity (Normalized) | −3,936.07% |
Return on Invested Capital (Normalized) | −122.86% |
Return on Assets
MOTS
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Kfdgktyn | Hlftpw | $196.1 Bil | |||
| Stryker Corp
SYK
| Nbrrbcykg | Twr | $137.7 Bil | |||
| Boston Scientific Corp
BSX
| Mjpsgvc | Zkndnvv | $122.3 Bil | |||
| Medtronic PLC
MDT
| Pcfqmlvqt | Fsdsngz | $114.7 Bil | |||
| Edwards Lifesciences Corp
EW
| Fqpnkmxqx | Nmwfzf | $39.6 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Blphf | Hkfs | $29.3 Bil | |||
| DexCom Inc
DXCM
| Kyqvhqmm | Mxbq | $27.1 Bil | |||
| Steris PLC
STE
| Hxbbxknm | Dzgpt | $23.3 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Cfxjxsvp | Xqn | $21.9 Bil | |||
| Insulet Corp
PODD
| Fjzlrgsm | Bvtqqqd | $16.5 Bil |
United States